184
Views
13
CrossRef citations to date
0
Altmetric
Review

A Review of Research Progress on Glycemic Variability and Gestational Diabetes

, , , , &
Pages 2729-2741 | Published online: 04 Aug 2020

References

  • Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993–2009. Matern Child Health J. 2015;19(3):635–642. doi:10.1007/s10995-014-1553-5
  • Mukesh M.Agarwal, Michel Boulvain, Edward Coetzee, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract. 2014;103(3):341–363. doi:10.1016/j.diabres.2013.10.012
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes–2020. Diabetes Care. 2020;43(Suppl1):S14–s31. doi:10.2337/dc20-S002
  • Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173–s211. doi:10.1016/S0020-7292(15)30033-3
  • Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682. doi:10.2337/dc10-0719
  • Society. CD. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chin J Pract Intern Med. 2018;38(4):292–344.
  • gynecology Csooa. Guidelines for the diagnosis and treatment of gestational diabetes mellitus. Diabetes World. 2014;8(11):489–498.
  • Gestational Diabetes Mellitus. ACOG Practice Bulletin No. 190. Obstet Gynecol. 2018;131(2):e49–e64. doi:10.1097/AOG.0000000000002501
  • Noctor E, Crowe C, Carmody LA, et al. Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria. Eur J Endocrinol. 2016;175(4):287–297. doi:10.1530/EJE-15-1260
  • Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29(11):2433–2438. doi:10.2337/dc06-1085
  • Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19(3):178–181. doi:10.1016/j.jdiacomp.2004.10.001
  • Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther. 2018;20(S2):S25–s215. doi:10.1089/dia.2018.0092
  • Škrha J, Šoupal J, Škrha J, Prázný M. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016;17(1):103–110. doi:10.1007/s11154-016-9347-2
  • Smith-Palmer J, Brändle M, Trevisan R, Orsini Federici M, Liabat S, Valentine W. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(3):273–284. doi:10.1016/j.diabres.2014.06.007
  • Gorst C, Kwok CS, Aslam S, et al. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354–2369. doi:10.2337/dc15-1188
  • Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Ther. 2019;10(3):853–863. doi:10.1007/s13300-019-0619-1
  • Law GR, Alnaji A, Alrefaii L, et al. Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care. 2019;42(5):810–815. doi:10.2337/dc18-2212
  • Panyakat WS, Phatihattakorn C, Sriwijitkamol A, Sunsaneevithayakul P, Phaophan A, Phichitkanka A. Correlation between third trimester glycemic variability in non-insulin-dependent gestational diabetes mellitus and adverse pregnancy and Fetal outcomes. J Diabetes Sci Technol. 2018;12(3):622–629. doi:10.1177/1932296817752374
  • Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014;99(12):4674–4682. doi:10.1210/jc.2013-4332
  • Dalfrà MG, Chilelli NC, Di Cianni G, et al. Glucose fluctuations during gestation: an additional tool for monitoring pregnancy complicated by diabetes. Int J Endocrinol. 2013;2013:279021. doi:10.1155/2013/279021
  • Boyd E.Metzger, Lynn P. Lowe, Alan R. Dyer, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453–459. doi:10.2337/db08-1112
  • Picconi F, Di Flaviani A, Malandrucco I, Giordani I, Frontoni S. Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. Nutr Metab Cardiovasc Dis. 2012;22(9):691–696. doi:10.1016/j.numecd.2012.03.006
  • Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902–1912. doi:10.2337/diacare.26.6.1902
  • Meigs JB, Nathan DM, D’Agostino RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25(10):1845–1850. doi:10.2337/diacare.25.10.1845
  • Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl 2):B21–29.
  • Ceriello A, Ihnat MA. ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27(8):862–867. doi:10.1111/j.1464-5491.2010.02967.x
  • Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349–1354. doi:10.2337/db08-0063
  • Reece EA, Homko CJ. Prepregnancy care and the prevention of fetal malformations in the pregnancy complicated by diabetes. Clin Obstet Gynecol. 2007;50(4):990–997. doi:10.1097/GRF.0b013e31815a634b
  • Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33(6):1389–1394. doi:10.2337/dc09-2082
  • Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A. Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract. 2007;75(1):42–46. doi:10.1016/j.diabres.2006.05.019
  • Mazze R, Yogev Y, Langer O. Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy. J Matern Fetal Neonatal Med. 2012;25(7):1171–1175. doi:10.3109/14767058.2012.670413
  • Su JB, Wang XQ, Chen JF, et al. Glycemic variability in gestational diabetes mellitus and its association with β cell function. Endocrine. 2013;43(2):370–375. doi:10.1007/s12020-012-9753-5
  • Dalfrà MG, Sartore G, Di Cianni G, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther. 2011;13(8):853–859. doi:10.1089/dia.2010.0145
  • Nigam A, Sharma S, Varun N, Munjal YP, Prakash A. Comparative analysis of 2-week glycaemic profile of healthy versus mild gestational diabetic pregnant women using flash glucose monitoring system: an observational study. Bjog. 2019;126(Suppl 4):27–33. doi:10.1111/1471-0528.15849
  • Cypryk K, Pertyńska-Marczewska M, Szymczak W, Wilcyński J, Lewiński A. Evaluation of metabolic control in women with gestational diabetes mellitus by the continuous glucose monitoring system: a pilot study. Endocr Pract. 2006;12(3):245–250. doi:10.4158/EP.12.3.245
  • Wang Y, Storlien LH, Jenkins AB, et al. Dietary variables and glucose tolerance in pregnancy. Diabetes Care. 2000;23(4):460–464. doi:10.2337/diacare.23.4.460
  • Porter H, Lookinland S, Belfort MA. Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study. J Perinat Neonatal Nurs. 2004;18(2):93–102. doi:10.1097/00005237-200404000-00004
  • Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9):644–655. doi:10.2337/diab.19.9.644
  • Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11(Suppl 1):S55–67. doi:10.1089/dia.2008.0132
  • McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther. 2005;7(2):253–263. doi:10.1089/dia.2005.7.253
  • Rodbard D. Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol. 2007;1(1):62–71. doi:10.1177/193229680700100111
  • endocrinology Cso. Experts consensus on management of glycemic variability of diabetes mellitus. Drug Evaluation. 2017;014(17):5–8,14.
  • Foreman YD, Brouwers M, van der Kallen CJH, et al. Glucose variability assessed with continuous glucose monitoring: reliability, reference values, and correlations with established glycemic indices – the Maastricht study. Diabetes Technol Ther. 2020;22:395–403. doi:10.1089/dia.2019.0385
  • Li C, Liu C, Nissim I, et al. Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine. J Biol Chem. 2013;288(6):3938–3951. doi:10.1074/jbc.M112.385682
  • Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C. The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set. Diabetes Technol Ther. 2019;21(1):1–5. doi:10.1089/dia.2018.0362
  • Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111(1):9–14. doi:10.1016/S0301-2115(03)00154-4
  • Murtaugh MA, Jacobs DR, Moran A, Steinberger J, Sinaiko AR. Relation of birth weight to fasting insulin, insulin resistance, and body size in adolescence. Diabetes Care. 2003;26(1):187–192. doi:10.2337/diacare.26.1.187
  • Voormolen DN, DeVries JH, Sanson RME, et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes Obes Metab. 2018;20(8):1894–1902. doi:10.1111/dom.13310
  • Pintaudi B, Di Vieste G, Corrado F, et al. Effects of myo-inositol on glucose variability in women with gestational diabetes. Eur Rev Med Pharmacol Sci. 2018;22(19):6567–6572. doi:10.26355/eurrev_201810_16073
  • Corrado F, D’Anna R, Di Vieste G, et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011;28(8):972–975. doi:10.1111/j.1464-5491.2011.03284.x
  • Costabile L, Unfer V. Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):73–76.
  • Carreiro MP, Lauria MW, Naves GN, et al. Seventy two-hour glucose monitoring profiles in mild gestational diabetes mellitus: differences from healthy pregnancies and influence of diet counseling. Eur J Endocrinol. 2016;175(3):201–209. doi:10.1530/EJE-16-0015
  • Rasmussen L, Christensen ML, Poulsen CW, et al. Effect of high versus low carbohydrate intake in the morning on glycemic variability and glycemic control measured by continuous blood glucose monitoring in women with gestational diabetes mellitus – a randomized crossover study. Nutrients. 2020;12(2):475. doi:10.3390/nu12020475
  • Kizirian NV, Goletzke J, Brodie S, et al. Lower glycemic load meals reduce diurnal glycemic oscillations in women with risk factors for gestational diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000351. doi:10.1136/bmjdrc-2016-000351
  • American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl1):S183–s192. doi:10.2337/dc20-S014
  • Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631–1640. doi:10.2337/dc17-1600
  • Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254–2263. doi:10.1016/S0140-6736(16)31535-5
  • Kropff J, Choudhary P, Neupane S, et al. Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal tRial. Diabetes Care. 2017;40(1):63–68. doi:10.2337/dc16-1525
  • Administration UFaD. FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices. Fda News Release. 2018.
  • Chitayat L, Zisser H, Jovanovic L. Continuous glucose monitoring during pregnancy. Diabetes Technol Ther. 2009;11(Suppl 1):S105–111. doi:10.1089/dia.2008.0136
  • Cypryk K, Bartyzel L, Zurawska-Klis M, et al. Continuous glucose monitoring in type 1 diabetes pregnancy shows that fetal heart rate correlates with maternal glycemia. Diabetes Technol Ther. 2015;17(9):619–624. doi:10.1089/dia.2014.0255
  • Slattery D, Choudhary P. Clinical use of continuous glucose monitoring in adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(S2):S55–s61. doi:10.1089/dia.2017.0051
  • Afandi B, Hassanein M, Roubi S, Nagelkerke N. The value of continuous glucose monitoring and self-monitoring of blood glucose in patients with gestational diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract. 2019;151:260–264. doi:10.1016/j.diabres.2019.01.036
  • Wei Q, Sun Z, Yang Y, Yu H, Ding H, Wang S. Effect of a CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: a randomized controlled trial. Sci Rep. 2016;6:19920. doi:10.1038/srep19920
  • Alfadhli E, Osman E, Basri T. Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes. Diabetol Metab Syndr. 2016;8:48. doi:10.1186/s13098-016-0161-5
  • McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol. 2007;47(3):186–190. doi:10.1111/j.1479-828X.2007.00716.x
  • Xie Y, Agiro A, Bowman K, DeVries A. Lowering cost share may improve rates of home glucose monitoring among patients with diabetes using insulin. J Manag Care Spec Pharm. 2017;23(8):884–891. doi:10.18553/jmcp.2017.23.8.884
  • Yeaw J, Lee WC, Aagren M, Christensen T. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes. J Manag Care Pharm. 2012;18(1):21–32. doi:10.18553/jmcp.2012.18.1.21
  • Rodbard D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther. 2016;18(Suppl2):S3–s13. doi:10.1089/dia.2015.0417